DBV技術 DBVT 深 滬
交易中 07-18 11:31:59 美东时间
10.25
+0.540
+5.56%
華盛通- 最 高10.26
- 今 開9.79
- 成交量 5751股
- 最 低 9.79
- 昨 收 9.71
- 總市值 2.80亿
- 52周最高 12.78
- 市盈率 靜 --
- 換手率 0.02%
- 52周最低 2.2045
- 委 比 51.22%
- 總股本 2734.77万
- 歷史最高 505.70
- 量 比 1.79
- 振 幅 4.84%
- 歷史最低 3.15
- 每 手 1
- 風險率 0.43%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅61.27%！Loop Capital上调英伟达目标价至250美元，维持"买入"评级
今日重点评级关注：Benchmark：维持特斯拉(TSLA)"买入"评级，目标价从350美元升至475美元>>
06-27 08:37
DBV Technologies Announces It Has Screened The First Subject In COMFORT Toddlers Supplemental Safety Study In Peanut Allergic Toddlers 1 – 3 Years Old
DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 – 3 Years OldFirst subject screened at the Respiratory Medicine Research Institute of Michigan
06-26 04:16
DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document
DBV Technologies has filed an addendum to its 2024 Universal Registration Document with the French financial regulator, detailing exceptional compensation granted to its CEO. The payment requires approval at the Annual Combined General Meeting on June 11. The Addendum, along with the URD, is available on DBV’s and AMF’s websites, and printed copies are accessible at DBV’s headquarters. DBV Technologies is a biopharmaceutical company developing tr...
06-03 20:30
美股大行评级 | 英伟达、赛富时、C3.ai、Veeva Systems等获多家机构上调目标价！
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1135136987677396993.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 摩根大通：维持Cogent Biosciences(COGT)"超配"评级，目标价从21美元升至25美元</p> <p>• Chardan Capital：维持Taysha Gene Therapies(TSHA)"买入"
05-30 09:09
美股大行评级 | 潜在涨幅1562.13%！Cingulate获Ascendiant Capital升目标价至61美元，维持"买入"评级
潜在涨幅1562.13%！Cingulate获Ascendiant Capital升目标价至61美元，维持"买入"评级
05-28 09:04
PTC Therapeutics To Rally Around 61%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a comple...
05-27 22:04
JMP Securities Maintains Market Outperform on DBV Technologies, Raises Price Target to $21
JMP Securities analyst Jonathan Wolleben maintains DBV Technologies (NASDAQ:DBVT) with a Market Outperform and raises the price target from $15 to $21.
05-27 19:31
DBV Technologies files to sell 289M ordinary shares for holders
DBV Technologies (NASDAQ:DBVT) filed to sell 289M ordinary shares for holders. Filing More on DBV Technologies DBV Technologies: A Great Time To Sell DBV Technologies announces up to $307M financing t...
05-20 04:23
Why Everus Construction Group Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Shares of Everus Construction Group, Inc. (NYSE:ECG) rose sharply in today's pr...
05-14 17:20
DBV Technologies GAAP EPS of -$0.26
DBV Technologies press release (NASDAQ:DBVT): Q1 GAAP EPS of -$0.26. Cash and cash equivalents amounted to $13.0 million as of March 31, 2025, compared to $32.5 million as of December 31, 2024, a net ...
05-01 05:38
